Detection of H pylori antibody profile in serum by protein array

World Journal of Gastroenterology

Volumn 12, Issue 25, 2006, Pages 4044-4048

  Han, Feng Chan ^a   Li, Xu Jun ^a   Jiang, Hong ^a   Qin, Li Peng ^a   Li, Ding ^a   Guo, Yan Hai ^a   Liu, Zhi Guang ^a   Zhang, Li ^b   Yan, Xiao Jun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Burn and Plastic Surgery   (China)

Author keywords

Antibody; Helicobacter pylori; Immunogold; Protein array

Indexed keywords

BACTERIUM ANTIBODY; CAGA PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PYROXYLIN; RECOMBINANT ANTIGEN; STAPHYLOCOCCUS PROTEIN A; UREASE; VACUOLATING TOXIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; COLLOID; CONTROLLED STUDY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITAL PATIENT; HUMAN; IMMUNOGOLD STAINING; INCUBATION TIME; PEPTIC ULCER; PROTEIN MICROARRAY; REPRODUCIBILITY; ROBOTICS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

EID: 33746217601     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i25.4044     Document Type: Article

References (37)

1. Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther 2001; 15: 1271-1290
2. Sanders MK, Peura DA. Helicobacter pylori-Associated Diseases. Curr Gastroenterol Rep 2002; 4: 448-454
3. Dawsey SM, Mark SD, Taylor PR, Limburg PJ. Gastric cancer and H pylori. Gut 2002; 51: 457-458
4. Blaser MJ. Linking Helicobacter pylori to gastric cancer. Nat Med 2000; 6: 376-377
5. Unger Z, Molnar B, Pronai L, Szaleczky E, Zagoni T, Tulassay Z. Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol 2003; 15: 389-393
6. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH. Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol 2003; 56: 19-24
7. Meining A, Riedl B, Stolte M. Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol 2002; 55: 770-773
8. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795
9. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91: 949-953
10. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-10575
11. Prinz C, Hafsi N, Voland P. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol 2003; 11: 134-138
12. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-1333
13. Tanaka J, Suzuki T, Mimuro H, Sasakawa C. Structural definition on the surface of Helicobacter pylori type IV secretion apparatus. Cell Microbiol 2003; 5: 395-404
14. Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 2003; 22: 515-528
15. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268
16. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003; 161: 249-255
17. Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C. Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell 2002; 10: 745-755
18. Cohen H, Rose S, Lewin DN, Retama B, Naritoku W, Johnson C, Bautista L, Crowe H, Pronovost A. Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori. Helicobacter 1999; 4: 49-53
19. de Arruda SM, Passaro DJ, Parsonnet J. Variability of serologic testing for H. pylori using U.S. and Peruvian antigens. Gastroenterology 2001; 120: 325-326
20. Wiese R, Belosludtsev Y, Powdrill T, Thompson P, Hogan M. Simultaneous multianalyte ELISA performed on a microarray platform. Clin Chem 2001; 47: 1451-1457
21. Mendoza LG, McQuarry P, Mongan A, Gangadharan R, Brignac S, Eggers M. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques 1999; 27: 778-780, 782-786, 788
22. Liang RQ, Tan CY, Ruan KC. Colorimetric detection of protein microarrays based on nanogold probe coupled with silver enhancement. J Immunol Methods 2004; 285: 157-163
23. Han FC, Yan XJ, Su CZ. Expression of the CagA gene of H. pylori and application of its product. World J Gastroenterol 2000; 6: 122-124
24. Templin MF, Stoll D, Schrenk M, Traub PC, Vohringer CF, Joos TO. Protein microarray technology. Trends Biotechnol 2002; 20: 160-166
25. Stoll D, Templin MF, Schrenk M, Traub PC, Vohringer CF, Joos TO. Protein microarray technology. Front Biosci 2002; 7: C13-32
26. Bacarese-Hamilton T, Mezzasoma L, Ardizzoni A, Bistoni F, Crisanti A. Serodiagnosis of infectious diseases with antigen microarrays. J Appl Microbiol 2004; 96: 10-17
27. Bacarese-Hamilton T, Ardizzoni A, Gray J, Crisanti A. Protein arrays for serodiagnosis of disease. Methods Mol Biol 2004; 264: 271-283
28. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, Crisanti A. Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem 2002; 48: 121-130
29. Angenendt P. Progress in protein and antibody microarray technology. Drug Discov Today 2005; 10: 503-511
30. Yakoob J, Fan XG, Peng XN, Hu GL, Zhang Z. Helicobacter pylori CagA and vacA cytotoxin genes in Changsha, China. Br J Biomed Sci 2002; 59: 150-153
31. Hua J, Zheng PY, Yeoh KG, Ho B. The status of the cagA gene does not predict Helicobacter pylori-associated peptic ulcer disease in Singapore. Microbios 2000; 102: 113-120
32. Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, Shiratori Y, Omata M. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1998; 42: 338-343
33. Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun 2000; 68: 915-920
34. Bjorkholm BM, Oh JD, Falk PG, Engstrand LG, Gordon JI. Genomics and proteomics converge on Helicobacter pylori. Curr Opin Microbiol 2001; 4: 237-245
35. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, Falkow S. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc Natl Acad Sci USA 2000; 97: 14668-14673
36. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-773
37. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, Tham KT, Camorlinga M, Blaser MJ, Falkow S, Peek RM Jr. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107: 611-620